AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
T-cell Engaging Antibodies for Multiple Myeloma
This chapter discusses the use of T-cell engaging antibodies for multiple myeloma, focusing on BCMA as a potential target. It explores different bi-specific antibodies and CAR-T therapy, highlighting their activity and toxicities. The speakers also discuss factors to consider when selecting the appropriate therapy for patients with multiple myeloma.